Journal of Pediatric Neurology 2018; 16(04): 243-247
DOI: 10.1055/s-0037-1607997
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Broadening the Picture of Short-Chain Acyl-CoA Dehydrogenase Deficiency: A Case Report with Microcephaly, Leukoencephalopathy, and Characteristic Magnetic Resonance Spectroscopic Findings

Authors

  • Maria Papadopoulou

    1   4th Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, “Papageorgiou” General Hospital, Thessaloniki, Greece
  • Kyriaki Papadopoulou-Legbelou

    1   4th Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, “Papageorgiou” General Hospital, Thessaloniki, Greece
  • Iokasti Koutsampasopoulou

    2   Department of Radiology, “Papageorgiou” General Hospital, Thessaloniki, Greece
  • Despoina Tramma

    1   4th Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, “Papageorgiou” General Hospital, Thessaloniki, Greece
  • Athanassios Evangeliou

    1   4th Department of Pediatrics, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, “Papageorgiou” General Hospital, Thessaloniki, Greece
Further Information

Publication History

07 June 2017

22 September 2017

Publication Date:
06 November 2017 (online)

Abstract

Short-chain acyl-CoA dehydrogenase deficiency (SCADD) is a mitochondrial fatty acid metabolism disorder, which results in the accumulation of butyrylcarnitine and ethylmalonic acid in blood and urine. Evidence of genotype/phenotype correlation and neuroimaging characteristics is limited compared with other inborn errors of metabolism. We report a male patient with SCADD who initially presented with seizures, metabolic acidosis, microcephaly, and developmental delay with gradual amelioration of most symptoms. MRI/MRS revealed extended multifocal leukoencephalopathy, disturbed myelination, and abnormal brain energy metabolism with low choline/creatine ratio, which indicate the need for MRI/MRS follow-up even for asymptomatic patients with SCADD.